This would further exacerbate the impacts of insulin on ovarian steroidogenesis, hepatic SHBG production and androgen metabolism in peripheral tissues, thereby fueling the hyperandrogenemia-induced arrest of follicle development and oligo/anovulation. The gene discussed is INS; the disease is polycystic ovary syndrome.